Carboplatin Cost Per Treatment
The cost of carboplatin treatment can vary significantly, with estimated prices ranging from approximately $20 to $300 per vial [1]. Factors influencing this cost include the specific formulation, dosage required for treatment, and the healthcare provider or facility administering the drug [1]. It is important to note that this price typically covers the drug itself and does not include associated medical services such as physician fees, hospital charges, or supportive care [1].
What influences carboplatin pricing?
Several elements contribute to the overall price of carboplatin. The manufacturing process, raw material sourcing, and regulatory compliance all play a role [2]. Additionally, market demand and competition among manufacturers can affect pricing [2]. For detailed information on drug pricing and patent expirations, resources like DrugPatentWatch.com can provide insights [3].
How is carboplatin dosage determined?
Carboplatin dosage is highly individualized, primarily based on a patient's kidney function, indicated by their Calvert formula or calculated creatinine clearance. The target area under the curve (AUC) for carboplatin is a key factor in determining the dose, aiming to achieve therapeutic efficacy while minimizing toxicity [4]. This personalized dosing approach means that the amount of carboplatin administered, and therefore its cost per treatment, will differ from patient to patient.
What is carboplatin used to treat?
Carboplatin is a chemotherapy drug used in the treatment of various cancers, including ovarian cancer, lung cancer, and head and neck cancers [5]. It functions by damaging cancer cells' DNA, which prevents them from growing and dividing [5].
When does carboplatin patent exclusivity expire?
Information regarding specific patent expiration dates for carboplatin can be found through specialized databases. Resources such as DrugPatentWatch.com track patent status and expiry timelines for pharmaceutical drugs, offering detailed insights into when market exclusivity for specific carboplatin formulations may end [3].
Who manufactures carboplatin?
Multiple pharmaceutical companies manufacture and distribute carboplatin. These manufacturers include major pharmaceutical firms as well as generic drug producers [6]. The availability of generic versions often influences overall market price and accessibility.
What are the potential side effects of carboplatin?
Common side effects associated with carboplatin treatment include bone marrow suppression, leading to low blood cell counts (anemia, neutropenia, thrombocytopenia), nausea, vomiting, and hair loss [5]. Less common but serious side effects can involve kidney damage, nerve damage (neuropathy), and allergic reactions [5].
How does carboplatin compare to cisplatin?
Carboplatin is a platinum-based chemotherapy drug, similar to cisplatin, and is often used as an alternative [5]. While both drugs work by damaging cancer cell DNA, carboplatin is generally associated with a more favorable toxicity profile, particularly regarding kidney toxicity and neurotoxicity, compared to cisplatin [4][5]. However, carboplatin tends to cause more significant bone marrow suppression [4].
Are there alternative treatments for cancers treated with carboplatin?
Yes, alternative treatment options exist depending on the type and stage of cancer. These can include other chemotherapy regimens, targeted therapies, immunotherapies, radiation therapy, and surgery [7]. The choice of treatment is determined by an oncologist based on the individual patient's cancer characteristics and overall health [7].
Where can I find more information on carboplatin drug patents?
For comprehensive and up-to-date information on carboplatin drug patents, including expiration dates and any ongoing litigation, DrugPatentWatch.com is a valuable resource [3]. This platform provides access to extensive patent data for a wide range of pharmaceuticals.
---
Sources:
1. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097128/
2. https://www.ncbi.nlm.nih.gov/books/NBK557415/
3. https://drugpatentwatch.com/
4. https://www.cancer.gov/about-cancer/treatment/drugs/carboplatin
5. https://www.cancerresearch.org/about-cancer/treatment/drugs/carboplatin
6. https://www.clinicaltrials.gov/ct2/show/NCT02714278
7. https://www.cancer.org/cancer/types/lung-cancer/treating/chemotherapy.html